Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico Insights.

Abstract : Preventing the spread of infectious diseases remains an urgent priority worldwide, and this is driving the development of advanced nanotechnology to diagnose infections at the point of care. Herein, we report the creation of a library of novel nanobody capture ligands to detect p24, one of the earliest markers of HIV infection. We demonstrate that these nanobodies, one tenth the size of conventional antibodies, exhibit high sensitivity and broad specificity to global HIV-1 subtypes. Biophysical characterization indicates strong 690 pM binding constants and fast kinetic on-rates, 1 to 2 orders of magnitude better than monoclonal antibody comparators. A crystal structure of the lead nanobody and p24 was obtained and used alongside molecular dynamics simulations to elucidate the molecular basis of these enhanced performance characteristics. They indicate that binding occurs at C-terminal helices 10 and 11 of p24, a negatively charged region of p24 complemented by the positive surface of the nanobody binding interface involving CDR1, CDR2, and CDR3 loops. Our findings have broad implications on the design of novel antibodies and a wide range of advanced biomedical applications.
Type de document :
Article dans une revue
ACS infectious diseases, 2017, 〈10.1021/acsinfecdis.6b00189〉
Liste complète des métadonnées

http://hal.univ-grenoble-alpes.fr/hal-01561577
Contributeur : Frank Thomas <>
Soumis le : jeudi 13 juillet 2017 - 09:45:14
Dernière modification le : dimanche 17 juin 2018 - 11:02:02

Lien texte intégral

Identifiants

Collections

Citation

Eleanor R Gray, Jennifer C Brookes, Christophe Caillat, Valérian Turbé, Benjamin L J Webb, et al.. Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico Insights.. ACS infectious diseases, 2017, 〈10.1021/acsinfecdis.6b00189〉. 〈hal-01561577〉

Partager

Métriques

Consultations de la notice

235